To determine whether attenuated IGF2 levels were associated with AD neuropathology, we measured Aβ42 levels in the cerebrum, liver, and blood plasma of young and aged 5xFAD mice (Fig. 2a–c). This evidence concerns the gene IGF2 and Alzheimer disease.